RxDoctor Payments Data

Michael Evan, MD

Family Medicine · Poland, OHNPI 1336123124

Payments from drug & device makers

$4,349in general payments, 2019–2025

Across 284 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$872
  • Amgen$330
  • Teva Pharmaceuticals USA, Inc.$316
  • Novo Nordisk$307
  • Pfizer$306
  • Merck$181
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$4,31199%
  • Education$381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,349 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$182,442
Medicare patients
378
Services billed
4,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban298$231,346
JardianceEmpagliflozin161$166,163
TrulicityDulaglutide57$70,844
OzempicSemaglutide40$47,864
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog45$43,094
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$30,833
XareltoRivaroxaban37$30,357
Tresiba Flextouch U-100Insulin Degludec37$27,269
JanuviaSitagliptin Phosphate24$25,758
FarxigaDapagliflozin Propanediol23$22,350
MounjaroTirzepatide12$19,145
LinzessLinaclotide13$14,687
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$11,501
Spiriva RespimatTiotropium Bromide11$8,799
SynthroidLevothyroxine Sodium148$7,603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$306$231,346298 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$22$180,644183 claims
Lilly USA, LLCTrulicity, Mounjaro$54$89,99069 claims
Novo NordiskOzempic$307$47,86440 claims
GSKTrelegy Ellipta, Breo Ellipta$26$36,10361 claims
Johnson & JohnsonXarelto$180$30,35737 claims
MerckJanuvia$181$25,75824 claims
AstraZenecaFarxiga$148$22,35023 claims
AbbVieLinzess, Synthroid$872$22,290161 claims
Sumitomo Pharma America, Inc.Gemtesa$17$5,04411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Poland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →